Loading

Clinical Research in Infectious Diseases

Aseptic Noninfective Meningitis: Etiologic Survey

Review Article | Open Access | Volume 3 | Issue 5

  • 1. Department of Internal Medicine, Military Hospital of Gabès, Tunisia
+ Show More - Show Less
Corresponding Authors
Salem Bouomrani, Department of Internal medicine, Military Hospital of Gabès, Gabès, 6000, Tunisia, Tel: 002-16 9-897-7555.
Abstract

Aseptic non infective meningitis are rare but represent a veritable diagnostic challenge to the clinician because their clinical and cerebrospinal fluid profile are similar to those of classic infectious meningitis. The most frequent etiologies of these meningitis are: systemic diseases, drugs, and neoplasms but several other exceptional causes can also be found. The aim of this review is expose the different possible causes to evoke and discuss in patient with aseptic meningitis (infectious causes excluded).
 

Keywords

• Meningitis

• Aseptic meningitis

• Systemic diseases

• Neoplasm

• Drug-induced

• Vasculitis

Citation

Bouomrani S, Trabelsi S, Nouma H, Baïli H, Belgacem N, et al. (2016) Aseptic Noninfective Meningitis: Etiologic Survey. Clin Res Infect Dis 3(5): 1042.

INTRODUCTION

Definitions

Meningitis is defined by the existence of an acute or chronic inflammation of the meninges covering brain and spinal cord. The most frequent causes of these affections areinfections: viral, bacterial and uncommonly fungal meningitis.

Absence of an infectious agent in the cerebrospinal fluid definite “noninfective meningitis” or “aseptic meningitis” [1]. This meningitis can be acute, chronic or recurring especially in systemic diseases and can occurs with or without anomalies of the cerebrospinal fluid (CSF). The chronicity of meningitis is defined by the persistence of clinical signs and/or symptoms of meningitis for more than four weeks, and it occurs for less than 10% of all the cases of meningitis [2,3].

Recurrent meningitis are defined by as at least two clinically similar episodes of meningitic syndrome with an interval of clinical and cerebrospinal fluid normalization [2,3].

The most frequent etiologies of these noninfective meningitis are: connective tissue diseases, systemic or cerebral primitive vasculitis, drugs, neoplasms, and systemic granulomatosis [1]. Other exceptional causes can be listed: diabetes, physical nervous aggression and traumatism, neurological surgery, AIDS, and some connectivitis-like syndromes. However, it should be noted that in about 30% of the cases, no cause is identified inspite of an extensive etiologic investigation; Thus it is called “idiopathic meningitis” which is generally chronic and/or recurring [2,3].

In this review of the literature, we expose the different possible causes to evoke and discuss in patient with aseptic meningitis (infectious causes excluded).

ETIOLOGIES OF ASEPTIC NONINFECTIVE MENINGITIS

The most common causes are systemic diseases, drugs and cancers. Cerebral thrombosis are assimilated tosystemic diseases [1,2]. Less frequently other causes can be also seen: granulomatosis, angiitis, brain traumatisms or surgery and certain exceptional specific clinico-pathological entities.

Systemic diseases and vasculitis

Neurological involvement is common in systemic inflammatory diseases and cerebrospinal manifestations represent serious complicationsreflecting disease activity. Their prognosis is universally poor.

Aseptic meningitis is reported in systemic lupus erythematosus[4,5], mixed connective tissue disease [4], overlap syndrome [4], Sjogren’s syndrome [1,4,6], Behçet’s disease [1,7,8], sarcoïdosis[1,9], polychondritis[10,11], multiple sclerosis [12], systemic vasculitis, especially those affecting small vessels such as granulomatosis with polyangiitis (formerly Wegener’s granulomatosis)[1,13], Vogt-Koyanagi-Harada syndrome [14] and primary angiitis of central nervous system.

In systemic disorders, neurological complications including aseptic meningitiscan be the result of multiple mechanisms: intracranial vascular lesions (vasculitis and thrombosis), specific autoantibodies to neuronal antigens, ribosomes, and phospholipids, and inflammation related to local cytokine production [15-17]. Anti-U1RNP antibody was founded in 93% of patients with connective tissue diseases and aseptic meningitis [4]. Cerebrospinal fluid findings in these cases showed elevated levels of IgM, IgA, and IgG indexes resulting of intrathecal immunoglobulin synthesis [17]. As well as Interleukin-6 activity and anti-neuronal antibody (anti-N) are significantly elevated in the CSF [17].

Aseptic meningitis is also rarely noted in patients with Sweet syndrome [18,19], Still’s disease [20,21], cerebral vein thrombosis [1,22], Kikuchi-Fujimato disease [23,24], and Crohn’s disease [19,25], primary biliary cirrhosis [26], juvenile rheumatoid arthritis [27], and adult Kawasaki disease [28].

The exact frequency of meningitis caused by inflammatory or systemic diseases is not well known. In the largest cohort of adult patients with aseptic meningitis (180 patients and 83 cases of determined etiological diagnosis), the prevalence of systemic diseases was only of 4% [29].Authors approximately estimate the frequency of aseptic meningitis at17% in Behçet’s disease, 10% in Kikuchi-Fujimato disease, 5% in sarcoïdois, 1.6% in systemic lupus erythematosus, and less than 0.001% in Hashimoto disease [29].

Neoplastic meningitis

Neoplastic meningitis (NM) is due to malignant tumor cells dissemination into the subarachnoid space, and approximately 4 to 15% of patients with solid cancer have meningeal involvement [30,31]. These incidences stay under estimated and postmortem studies showed that 19% of patients with cancer and neurological signs or symptoms had evidence of meningeal involvement [32]. They are represented principally by carcinomatous meningitis or leptomeningeal carcinomatosis, leukemic and lymphomatous meningitis, primitive melanomatous meningitis, and gliomatous meningitis or meningeal gliomastosis. Rarely, NMare secondary to the contamination of the subarachnoid space by the contents of cystic brain tumors; they are called “chemical NM” and generally have excellent prognosis.

NM is diagnosed in breast carcinoma: 27-50%, lung carcinoma: 22-36%, medulloblastoma: 30%, melanoma: 20% [30,31,33,34] and lymphoma or leukemia: 5-15%. Myeloid meningitis is strongly associated with refractory disease; for this reason lumbar puncture should be performed in patient with acute leukemia, especially prior to hematopoietic stem cell transplantation [35]; More rarely, neoplastic meningitis may complicate prostate, testicular and colon cancer[31], multiple myeloma [36], and malignant tumors of the central nervous system [33,37,38]. In patient with primary brain tumors, meningitis occurs in 1-2% of cases [34]. NM from glioblastoma is especially fatal [37].Extremely NM may complicate renal carcinoma [39-41] and bladder cancer [42-45]. Finally in 1-7% of all cases it consists of carcinoma of unknown primary [46].

Usually meningitis occurs in patient with widely disseminated cancer, but it can be the first manifestation of neoplasm in 5-10% of cases [32]. Meningeal involvement in cancers can result directly from the disease: leptomeningeal metastasis, indirectly: paraneoplastic meningitis, or as a complication of chemotherapeutic agents: treatment-related meningitis [47,48]. One case of paraneoplastic meningitis was reported in a patient with Hodgkin’s lymphoma [47], and one case of aseptic meningitis with Trastuzumab as a treatment of bladder carcinoma [45].

NM is characterized by a very poor prognosis and the treatment consists of adapted chemotherapy and rarely located radiotherapy. Intrathecal treatment with topoisomerase I inhibitor can be successfully used in this case [37].

Drug-induced meningitis

Drug-induced aseptic meningitis (DIM) is a rare adverse effect of some drugs. They represent a veritable diagnostic challenge to the clinician [49-51] because their clinical and cerebrospinal fluid profile are similar to those of infectious meningitis [51,52]. The incidence of DIM is unknown.

The most common medications inducing aseptic meningitis include: antibiotics, non-steroidanti-inflammatory drugs, muromonab-CD3 (OKT3), and intravenous immunoglobulin [49- 59].

Other cases of aseptic meningitis has been reported with carbamazepine [60], sulfasalazine [61-63], serotonin uptake inhibitors [64], azathioprine [65], hepatitis B vaccination [66], measles-mumps-rubella vaccination[67]ranitidine [68], salicylate overdose [69], lamotrigine[70], leflunamide[71], spinal anaesthesia/intrathecal administration of bupivacaine [72,73], intramuscular methotrexate [74], ergot agents[75], and biologic agent (monoclonal antibodies/anti-TNF-α/epidermal growth factor receptor (EGFR) inhibitor) [76-80].

Latency from drug intake to the development of aseptic meningitis varies from few minutes toseveral months, and prior exposure to the drug can be noted in 3-45% of cases [51,52].

The exact pathogeny of DIM is poorly understood [51-53], some of cases are noted in patients with connective tissue diseases, autoimmune diseases or vasculitis[49,52,53,61,76,78,81,82] suggesting a possible predisposing immune dysregulation[53].

This hypothesis is supported by an abnormal upregulation of interleukin 6 in both cerebrospinal fluid and plasma associated with this type of meningitis [53,83-87]. Magnetic resonance imaging showed that DIM can be also associated with signal abnormalities of cerebrospinal white-matter that resolved several days after discontinuing the incriminated agent [49,52,83].

Hypersensitivity type I or III and cytokine release (mainly or exclusively limited to the CSF compartment) are possible mechanisms invoked in DIM pathogenesis [52,88]. For other authors, direct meningeal drug-toxicity/irritation is also evocated as a possible pathogenic mechanism of DIM [52,88].

Recurrent DIM was also reported (2 to 5 episodes in the same patient), especially with non-steroid anti-inflammatory drugs [89,90], antibiotics [91], OKT3 [86], and intravenous immunoglobulin [92]. Systemic diseases (systemic lupus erythematosus, Sjogren’s syndrome, undifferentiated connective tissue disease, and rheumatoid arthritis), idiopathic thrombocytopenic purpura, human immunodeficiency virus infection, and Crohn’s disease are the most frequent conditions associated with recurrent DIM [92-97].

Others exceptional causes

Exceptional causes can be also listed for NIM : fosted-branch angiitis [98], chronic urticaria [99], Fabry disease with ischemic stroke [100], posterior fossa dermoid cyst [101], intracranial epidermoid cyst [102,103], spontaneous rupture of spinal teratoma [104], trans-sphenoidal management of Rathke’s cleft cyst [105], glyphosate-surfactant herbicide poisoning [106], acute disseminated encephalomyelitis [107], SAPHO syndrome [108], brain surgery [109], metal fume fever complication of Zinc oxide fume inhalation [110], reaction to intracranial infections (brain or sinus) [111,112], scinti-cysternography with [111] indium-DTPA [113], and microdiscectomy [114].

Management of aseptic meningitis

The diagnosis of non-infectious aseptic meningitis is a real challenge for the clinician. Indeed, in most cases, neither clinical presentation nor cerebrospinal fluid characteristics are discriminative for etiologic diagnosis.

When we have aseptic meningitis, we have first to eliminate viral causes because they are responsible for the majority of these meningitis. The main causal viruses are: enteroviruses, Herpes Simplex Virus, Varicella Zoster Virus, West Nile Virus, Human Immunodeficiency Virus, mumps. Specific serological tests and PCR have a great contribution in these situations.

Subsequently, it is necessary to perform specific tests looking for bacterial or fungal causes that can lead to aseptic meningitis, mainly: tuberculosis, syphilis, brucellosis, Lyme disease, Cryptococcus neoformans. Specific tests can be realized in blood and in CSF to perform certitude diagnosis.

Benign recurrent aseptic meningitis or Mollaret’s meningitis caused by herpes simplex virus (principally HSV-2 and less frequently HSV-1), remains a main differential diagnoses for aseptic meningitis.

Finally, the diagnosis of non-infectious aseptic meningitis is based on a set of arguments: clinical, biological, immunological, and radiological:

- A complete and repetitive physical examination is necessary to look for signs of systemic involvement suggestive of system disease, granulomatosis or systemic vasculitis: rash, purpura, mucosal ulcers, aphthous ulceration, genital ulcers or scars, arthritis, synovitis, peripheral neuropathy, uveitis, pleurisy, pericarditis.

- The search for signs evoking cancer or hematologic malignancies such hepatomegaly, splenomegaly, lymphadenopathy or other organomegaly.

- Antecedent for atopy or allergy and the history of recent drug intakeare important to clarify, especially for the diagnosis of DIM.

- Specific additional tests will be required depending on the diagnostic orientation: screening of autoantibodies (antinuclear antibodies, antibodies to native DNA, antibodies to soluble antigens, ANCA (antineutrophil cytoplasmic antibodies c and p), and organ-specific autoantibodies), tumor markers, radiological investigations (ultrasound, CT-scans, MRI), bone marrow aspirate, bone marrow biopsy, genetic tests, endoscopic explorations, organ biopsies .

- Diagnosis of DIM must remain a diagnosis of exclusion after removing infectious, neoplastic and inflammatory causes. It is based on the notion of recent drug use, the temporal relationship between drug intake and onset of meningeal signs, negativity of cerebrospinal fluid (direct examination and cultures), and the resolution of meningeal symptoms after drug withdrawal.

CONCLUSION

Aseptic noninfective meningitis are uncommon but represent a veritable diagnostic challenge to the clinician because their clinical and cerebrospinal fluid profile are similar to those of infectious meningitis.

Their diagnosis rests on clinical symptoms of meningitis, typical biological findingsin the CSF, negativity of the infectious tests (bacterial, viral, parasitic and fungal), and a personal history of subjacent diseases (connectivities, autoimmunity, cancers, granulomatosis, vasculitis), drug catches, brain surgery or neurological invasive explorations.

Multiple causes can be listed and usually classified in three main groups: systemic diseases with meningeal involvement, neoplastic meningitis, and drug-induced aseptic meningitis. However, it should be noted that in about 30% of the cases, no cause is identified inspite of an extensive etiologic investigation; thus it is called “idiopathic meningitis” which is generally chronic and/or recurring.

REFERENCES

1. Tattevin P, Revest M, Lavoué S.Méningites et méningoencéphalites. Réanimation. 2008; 17: 639-650.

2. Ginsberg L, Kidd D. Chronic and recurrent meningitis. Pract Neurol. 2008; 8: 348-361.

3. Colombe B, Derradji M, Bosseray A, Massot C, Debru JL. [Chronic meningitis: aetiologies, diagnosis and treatment]. Rev Med Interne. 2003; 24: 24-33.

4. Okada J, Hamana T, Kondo H. Anti-U1RNP antibody and aseptic meningitis in connective tissue diseases. Scand J Rheumatol. 2003; 32: 247-252.

5. Honczarenko K, Budzianowska A, Ostanek L. Neurological syndromes in systemic lupus erythematosus and their association with antiphospholipid syndrome. Neurol Neurochir Pol. 2008; 42: 513-517.

6. Rossi R, Valeria Saddi M. Subacute aseptic meningitis as neurological manifestation of primary Sjögren’s syndrome. Clin Neurol Neurosurg. 2006; 108: 688-691.

7. Sakakibara R, Koide N, Kishi M, Ogawa E, Shirai K. Aseptic meningitis as the sole manifestation of Behçet’s disease. Neurol Sci. 2009; 30: 405-407.

8. Mullins GM, Elamin M, Saidha S, Ali E, Jennings L, Counihan TJ, et al. Acute aseptic meningitis and diffuse myelitis as the presenting features of neurological Behcet disease. J Clin Neurosci. 2009; 16: 1702-1704.

9. Held EP, Iglesia EA, Johnson AS, Fang JY, Wilson MH, Abel TW, et al. Neurosarcoidosis Presenting as Aseptic Meningitis in an Immunosuppressed Renal Transplant Recipient. Transplantation. 2016.

10. Yaguchi H, Tsuzaka K, Niino M, Yabe I, Sasaki H. Aseptic meningitis with relapsing polychondritis mimicking bacterial meningitis. Intern Med. 2009; 48: 1841-1844.

11. JM Ragnaud, M Buisson, P Morlat, ATabaz, H Gin, J Aubertin. Méningites puriformes aseptiques ré cidivantes au cours d’une polychondrite chronique atrophiante. Rev Med Int. 1994, 15: 115.

12. Al-Moallem MA, Zaidan RM, Alkali NH, Tahan AY. Multiple sclerosis with recurrent meningitis.Neurosciences (Riyadh). 2008; 13: 310- 313.

13. Berlit P. Diagnosis and treatment of cerebral vasculitis. Ther Adv Neurol Disord. 2010; 3: 29-42.

14. Touitou V, Escande C, Bodaghi B, Cassoux N, Wechsler B, Lemaitre C , et al. Diagnostic and therapeutic management of Vogt-Koyanagi-Harada syndrome. J Fr Ophtalmol. 2005; 28: 9-16. 

15. Bruns A, Meyer O. Neuropsychiatric manifestations of systemic lupus erythematosus. Joint Bone Spine. 2006; 73: 639-645.

16. Vadacca M, Buzzulini F, Rigon A, Coppolino G, Palma Modoni A, Massa R et al. Neuropsychiatric lupus erythematosus. Reumatismo. 2006; 58:177-186.

17. Hirohata S. Central nervous system involvement in connective tissue diseases. Nihon Rinsho Meneki Gakkai Kaishi. 2004; 27: 109-117.

18. Balass S, Duparc A, Zaïd S, Bularca S, Modiano P. Aseptic meningitis during Sweet syndrome. Ann Dermatol Venereol. 2005; 132: 1003- 1006.

19. Hiari N, Borland C. A 47-year-old man with neuro-Sweet syndrome in association with Crohn’s disease: a case report. J Med Case Rep. 2009; 3: 8997.

20. Akkara Veetil BM, Yee AH, Warrington KJ, Aksamit AJ Jr, Mason TG. Aseptic meningitis in adult onset Still’s disease. Rheumatol Int. 2012; 32: 4031-4034.

21. Sabnis GR, Gokhale YA, Kulkarni UP. Tocilizumab in refractory adultonset Still’s disease with aseptic meningitis--efficacy of interleukin-6 blockade and review of the literature. Semin Arthritis Rheum. 2011; 40: 365-368.

22. Collins JJ, Fisher WS 3rd. Vein of Galen aneurysm presenting with recurrent aseptic meningitis and subsequent spontaneous thrombosis. Surg Neurol. 1990; 33: 325-328.

23. Khishfe BF, Krass LM, Nordquist EK. Kikuchi disease presenting with aseptic meningitis. Am J Emerg Med. 2014; 32: 1298.

24. Dumas G, Prendki V, Haroche J, Amoura Z, Cacoub P, Galicier L et al. Kikuchi-Fujimoto disease: retrospective study of 91 cases and review of the literature. Medicine (Baltimore). 2014; 93: 372-382.

25. Manthey C, Lohse AW, Pace A. Case report of aseptic meningitis in a patient with Crohn’s disease under infliximab therapy. Inflamm Bowel Dis. 2011; 17.

26. Bensa C, Boscagli A, Bourg V, Bensaken S, Chanalet S, Lebrun C. Méningite récurrente aseptique associ e uneécirrhose biliaire primitive. Rev Neurol. 2005; 161: 87-91.

27. Cunha BA, Hage JE, Nouri Y. Recurrent fever of unknown origin (FUO): Aseptic meningitis, hepatosplenomegaly, pericarditis and a double quotidian fever due to juvenile rheumatoid arthritis (JRA). Heart Lung.2012; 41: 177-180.

28. McIlroy MA, Fisher EJ, Saravolatz LD, Hardwicke MB, Wilson FM. Aseptic meningitis complicating adult Kawasaki disease: case report and review of the literature. Am J Med. 1989; 87: 106-110.

29. JarrinI, Sellier P, Lopes A, Morgand M, Makovec T, Delcey V et al. Etiologies and Management of Aseptic Meningitis in Patients Admitted to an Internal Medicine Department. Medicine (Baltimore). 2016; 95: 2372.

30. Chamberlain MC. Neoplastic meningitis. J Clin Oncol. 2005; 23: 3605- 3613.

31. Chamberlain MC, Johnston SK. Neoplastic meningitis: survival as a function of cerebrospinal fluid cytology. Cancer. 2009; 115: 1941- 1946.

32. Glass JP, Melamed M, Chernik NL, Posner JB. Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology. 1979; 29: 1369-1375.

33. Boskovitz A, McLendon RE, Okamura T, Sampson JH, Bigner DD, Zalutsky MR. Treatment of HER2 Positive Breast Carcinomatous Meningitis with Intrathecal Administration of a-Particle Emitting 211At-labeled Trastuzumab. Nucl Med Biol. 2009; 36: 659-669.

34. Chamberlain MC. Neoplastic meningitis. Oncologist. 2008; 13: 967- 977.

35. Bommer M, von Harsdorf S, Döhner H, Bunjes D, Ringhoffer M. Neoplastic meningitis in patients with acute myeloid leukemia scheduled for allogeneic hematopoietic stem cell transplantation. Haematologica. 2010; 95: 1969-1972.

36. Chamberlain MC, Glantz M. Myelomatous meningitis. Cancer. 2008; 112: 1562-1567.

37. Ochiai H, Pernell CT, Archer GE, Chewning TA, McLendon RE, Friedman HS, et al. Treatment of neoplastic meningitis with intrathecal 9-nitro-camptothecin. Neurol Med Chir (Tokyo). 2006; 46: 489-490.

38. Prados MD. Primary neoplasms of the central nervous system in adults. In: Kufe DW, editor. Cancer Medicine. 7th Edition. Hamilton, ON: BC Decker, 2006; 1037-1064.

39. Ranze O, Hofmann E, Distelrath A, Hoeffkes HG. Renal cell cancer presented with leptomeningeal carcinomatosis effectively treated with sorafenib. Onkologie. 2007; 30: 450-451.

40. Tippin DB, Reeves W, Vogelzang NJ. Diagnosis and treatment of leptomeningeal metastases in a patient with renal carcinoma responding to 5-fluorouracil and gemcitabine. J Urol. 1999; 162: 155- 156.

41. Dalhaug A, Haukland E, Nieder C. Leptomeningeal carcinomatosis from renal cell cancer: treatment attempt with radiation and sunitinib (case report). World J Surg Oncol. 2010; 8: 36.

42. Eng C, Cunningham D, Quade BJ, Schwamm L, Kantoff PW, Skarin AT. Meningeal carcinomatosis from transitional cell carcinoma of the bladder. Cancer. 1993; 72: 553-557.

43. Hara Y, Kobayashi Y, Goto K, Tozuka K, Tokue A, Mochizuki M. A case of carcinomatous meningitis from transitional cell carcinoma of the urinary bladder. Hinyokika Kiyo. 1994; 40: 1113-1117.

44. Matsushita M, Kawasaki Y, Okada Y. Carcinomatous meningitis from urothelial carcinoma of bladder and ureter: case report. Nihon Hinyokika Gakkai Zasshi. 2004; 95: 817-819.

45. Goodman OB, Milowsky MI, Kaplan J, Hussain M, Nanus DM. Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of the literature. J Med Case Reports. 2009; 3: 9110.

46. Wasserstrom WR, Glass JP, Posner JB. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer. 1982; 49: 759-772.

47. Vetter M, Tzankov A, Engert A, Mehling M, Herrmann R, Rochlitz C. Hodgkin’s Lymphoma and Paraneoplastic Phenomena in the Central Nervous System: A Case Report and Review of the Literature. Case Rep Oncol. 2011; 4: 106-114.

48. Grimm S, Chamberlain M. Hodgkin’s Lymphoma: A Review of Neurologic Complications. Adv Hematol. 2011; 2011.

49. Jolles S, Sewell WA, Leighton C. Drug-induced aseptic meningitis: diagnosis and management. Drug Saf. 2000; 22: 215-226.

50. Gordon MF, Allon M, Coyle PK. Drug-induced meningitis. Neurology. 1990; 40: 163-164.

51. Morís G, Garcia-Monco JC. The challenge of drug-induced aseptic meningitis revisited. JAMA Intern Med. 2014; 174: 1511-1512.

52. Moris G`, Garcia-Monco JC. The challenge of drug-induced aseptic meningitis. Arch Intern Med. 1999; 159: 1185-1194.

53. Redman RC, Miller JB, Hood M, DeMaio J. Trimethoprim-induced aseptic meningitis in an adolescent male. Pediatrics. 2002; 110.

54. Tuleja E, Bourgarit A, Abuaf N, Le Beller C, Séréni D. Rifampin-induced severe aseptic meningitis. Rev Med Interne. 2010; 31.

55. Prieto-González S, Escoda R, Coloma E, Grau JM. Amoxicillin-induced acute aseptic meningitis. J Clin Neurosci. 2011; 18: 443-444.

56. Mathanasenarajah G, Hoi A. Trimethoprim-induced aseptic meningitis: a reminder case review. Int J Rheum Dis. 2015; 20.

57. Mathanasenarajah G, Hoi A. Trimethoprim-induced aseptic meningitis: a reminder case review. Int J Rheum Dis. 2015; 20.

58. Andrés-del Olmo B, Demelo-Rodríguez P, Muñoz Delgado C, Sanz Sanz FJ. Ibuprofen-induced recurrent aseptic meningitis with good response to corticosteroids. Med Clin (Barc). 2016; 146: 140.

59. Puy-Nunez A, Dacosta-Balboa M, Cabo-Lopez I, Canneti B, Lopez-Ferreiro A, Rodriguez-Alvarez JR et al. Aseptic meningitis as a complication of immunoglobulin treatment in myasthenia gravis. Rev Neurol. 2016; 62: 478-479.

60. Jain RS, Kumar S, Aggarwal R, Kookna JC. Acute aseptic meningitis due to intravenous immunoglobulin therapy in Guillain-Barré syndrome. Oxf Med Case Reports. 2014; 2014: 132-134.

61. Hemet C, Chassagne P, Levade MH, Heron F, Fortier-Beaulieu M, Doucet J , et al. Aseptic meningitis secondary to carbamazepine treatment of manic-depressive illness. Am J Psychiatry. 1994; 151: 1393.

62. Merrin P, Williams IA. Meningitis associated with sulphasalazine in a patient with Sjögren’s syndrome and polyarthritis. Ann Rheum Dis. 1991; 50: 645-646.

63. Alloway JA, Mitchell SR. Sulfasalazine neurotoxicity: a report of aseptic meningitis and a review of the literature. J Rheumatol. 1993; 20: 409-411.

64. Houitte R, Abgueguen P, Masson C. Salazopyrine-induced aseptic meningitis. Joint Bone Spine. 2009; 76: 216-217.

65. Herlihy TE. Phenazopyridine and aseptic meningitis. Ann Intern Med. 1987; 106: 172-173.

66. Sergent JS, Lockshin MD, Klempner MS, Lipsky BA. Central nervous system disease in systemic lupus erythematosus. Therapy and prognosis. Am J Med. 1975; 58: 644-654.

67. Heinzlef O, Moguilewski A, Roullet E. Acute aseptic meningitis after hepatitis B vaccination. Presse Med. 1997; 26: 328.

68. Mamishi S, Sarkardeh M, Pourakbari B, Keshavarz Valian S, Sabouni F , et al. Aseptic meningitis after measles-mumps-rubella (MMR) vaccination. Br J Biomed Sci. 2016; 73: 84-86.

69. Durand JM, Suchet L, Morange S, Michel B. Ranitidine and aseptic meningitis. BMJ. 1996; 312: 886.

70. Nair J, Stacy M. Aseptic meningitis associated with salicylate overdose. Psychosomatics. 1993; 34: 372.

71. Green MA, Abraham MN, Horn AJ, Yates TE, Egbert M, Sharma A. Lamotrigine-induced aseptic meningitis: a case report. Int Clin Psychopharmacol. 2009; 24: 159-161.

72. Cohen JD, Jorgensen C, Sany J. Leflunomide-induced aseptic meningitis. Joint Bone Spine. 2004; 71: 243-245.

73. Ducornet A, Brousous F, Jacob C, Egreteau PY, Tonnelier JM. Meningitis after spinal anesthesia: think about bupivacaine!. Ann Fr Anesth Reanim. 2014; 33: 288-290.

74. Celik M, Kizilkaya M, Dostbil A, Dogan N, Parlak M, Can FK, et al. Meningitis following spinal anaesthesia in an obstetric patient. Trop Doct. 2014; 44: 179-181.

75. Hawboldt J, Bader M. Intramuscular methotrexate-induced aseptic meningitis. Ann Pharmacother. 2007; 41: 1906-1911.

76. Ogawa T, Tagawa A, Hashimoto R, Kato H. A case of recurrent aseptic meningitis induced by ergot agents. Rinsho Shinkeigaku. 2015; 55: 421-423.

77. Cavazzana I, Taraborelli M, Fredi M, Tincani A, Franceschini F. Aseptic meningitis occurring during anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol. 2014; 32: 732-734.

78. Shah R, Shah M, Bansal N, Manocha D. Infliximab-induced aseptic meningitis. Am J Emerg Med. 2014; 321560.

79. Honda Y, Otsuka A, Egawa G, Inoue Y, Kuzuya A, Takahashi R et al. Multiple neurological abnormalities, including pontine hemorrhage, multiple sclerosis and aseptic meningitis, during anti-TNF-a therapy in psoriatic arthritis. Eur J Dermatol. 2015; 25: 487-488.

80. Prasanna D, Elrafei T, Shum E, Strakhan M2. More than a headache: a case of cetuximab-induced aseptic meningitis. BMJ Case Rep. 2015.

81. Ulrich A, Weiler S, Weller M, Rordorf T, Tarnutzer AA. Cetuximab induced aseptic meningitis. J Clin Neurosci. 2015; 22: 1061-1063.

82. Faurie P, Pérard L, Hot A, Desmurs-Clavel H, Fassier T, Boibieux A et al. Méningite aseptique récidivante due aux anti-inflammatoires non stéroédiens chez une patiente lupique. Rev Med Interne. 2010;31.

83. García Norniella B, Morán Poladura M, Fernández Díaz M, Fernández Fernández E, Suárez Castañón C. Aseptic meningitis secondary to intravenous immunoglobulin treatment in Kawasaki disease. An Pediatr (Barc). 2011; 75: 79-80.

84. Bejoy T, Krishnamoorthya TH, Kapilamoorthya Tirur R. Contrast enhanced FLAIR imaging in ibuprofen induced aseptic meningitis. European Journal of Radiology Extra. 2006; 60: 97-99.

85. Antonen J, Saha H, Hulkkonen J, Lumio J, Pasternack A, Hurme M. Increased in vitro production of interleukin 6 in response to trimethoprim among persons with trimethoprim-induced systemic adverse reactions. J Rheumatol.1999; 26: 2585-2590.

86. Antonen J, Hulkkonen J, Pasternack A, Hurme M.Interleukin 6 may be an important mediator of trimethoprim-induced systemic adverse reaction resembling asepticmeningitis. Arch Intern Med. 2000; 160: 2066-2067.

87. Agarwal RK, Ostaszewski ML, Feld LG, Springate JE, Moxey-Mims MM, O’Neill KM. Tumor necrosis factor and interleukin-6 in cerebrospinal fluid of a patient with recurrent adverse central nervous system events following OKT3. Transplant Proc. 1993; 25: 3143-3144.

88. Fujita Y, Fujii T, Nakashima R, Tanaka M, Mimori T. Aseptic meningitis in mixed connective tissue disease: cytokine and anti-U1RNP antibodies in cerebrospinal fluids from two different cases. Mod Rheumatol. 2008; 18: 184-188.

89. Sepci???????? J, Bucuk M, Perkovi? O, Sepi?-Grahovac D, Troselj-Vuki? B, Poljak I , et al. Drug-induced aseptic meningitis, sensorineural hearing loss and vestibulopaty. Coll Antropol. 2010; 34: 1101-1104.

90. Jensen S, Glud TK, Bacher T, Ersgaard H. Ibuprofen-induced meningitis in a male with systemic lupus erythematosus. Acta Med Scand. 1987; 221: 509-511.

91. Farr KP, Mogensen CB. Drug-induced aseptic meningitis. Ugeskr Laeger. 2010; 172: 298-299.

92. Haas EJ. Trimethoprim-sulfamethoxazole: another cause of recurrent meningitis. JAMA. 1984; 252: 346.

93. Jayabose S, Roseman B, Gupta A. “Aseptic meningitis syndrome” after intravenous gammaglobulin therapy for ITP. Am J HematolOncol. 1990; 12: 117. 

94. Roel JE, Gadano AC, Falcón JL. Ketoprofen and aseptic meningitis. Medicina (B Aires). 1991; 512: 186.

95. Derbes SJ. Trimethoprim-induced aseptic meningitis. JAMA. 1984; 252: 2865-2866.

96. Joffe AM, Farley JD, Linden D, Goldsand G. Trimethoprim-sulfamethoxazole associated aseptic meningitis: case reports and review of the literature. Am J Med. 1989; 87: 332-338.

97. Agus B, Nelson J, Kramer N, Mahal SS, Rosenstein ED. Acute central nervous system symptoms caused by ibuprofen in connective tissue disease. J Rheumatol. 1990; 17: 1094-1096.

98. Harrison MS, Simonte SJ, Kauffman CA. Trimethoprim-induced aseptic meningitis in a patient with AIDS: case report and review. Clin Infect Dis. 1994; 19: 431-434.

99. Chaume A, Lemelle I, Chastagner P, Angioi K. A case report of frosted branch angiitis associated with aseptic meningitis in a young boy. J Fr Ophtalmol. 2011; 34.

100. Tanaka H, Waga S, Kakizaki Y, Sugimoto K, Nomura K, Yokoyama M. Chronic urticaria associated with aseptic meningitis: an atypical urticarial vasculitis? Acta Paediatr Jpn. 1997; 39: 64-68.

101. Lidove O, Chauveheid MP, Caillaud C, Froissart R, Benoist L, Alamowitch S , et al. Aseptic meningitis and ischaemic stroke in Fabry disease. Int J Clin Pract. 2009; 63: 1663-1667.

102. Ayuga-Loro F, Verdu-Perez A, Polo-Martin M, Garcia-Benassi JM. Acute ataxia and aseptic meningitis secondary to a posterior fossa dermoid cyst. Rev Neurol. 2009; 49: 334-336.

103. Achard JM, Lallement PY, Veyssier P. Recurrent aseptic meningitis secondary to intracranial epidermoid cyst and Mollaret’s meningitis: two distinct entities or a single disease? A case. Am J Med. 1990; 89: 807-810.

104. Terzis A.J.A, Kehler U, Sepehrmia A. Recurrent aseptic meningitisin ruptured intracranial dermoid. Case report. Clinical Neurology and Neurosurgery 1997; 99.

105. Mpayo LL, Liu XH, Xu M, Wang K, Wang J, Yang L. Extramedullary spinal teratoma presenting with recurrent aseptic meningitis. Pediatr Neurol. 2014; 50: 655-657.

106. Koutourousiou M, Seretis A. Aseptic meningitis after transsphenoidal management of Rathke’s cleft cyst: case report and review of the literature. Neurol Sci. 2011; 32: 323-326.

107. Sato C, Kamijo Y, Yoshimura K, Ide T. Aseptic meningitis in association with glyphosate-surfactant herbicide poisoning. Clin Toxicol (Phila). 2011; 49: 118-120.

108. Fujiki F, Tsuboi Y, Hori T, Yamada T. Aseptic meningitis as initial presentation of acute disseminated encephalomyelitis. J Neurol Sci. 2008; 272: 129-131.

109. Hiwatani Y, Miwa H, Kondo T. Aseptic meningitis as a rare manifestation of sapho syndrome. Neurology. 2008; 71: 1645-1647.

110. Dubey A, Sung WS, Shaya M, Patwardhan R, Willis B, Smith D , et al. Complications of posterior cranial fossa surgery--an institutional experience of 500 patients. Surg Neurol. 2009; 72: 369-375.

111. Hassaballa HA, Lateef OB, Bell J, Kim E, Casey L. Metal fume fever presenting as aseptic meningitis with pericarditis, pleuritis and pneumonitis. Occup Med (Lond). 2005; 55: 638-641.

112. Mollison WM. Non-infective Meningitis Five Months after Cerebral Abscess. Proc R Soc Med. 1913; 6: 14-16.

113. Brook I, Overturfa Gary D, Steinberga Evan A, Hawkinsa Donald B. Acute sphenoid sinusitis presenting as aseptic meningitis:apachymeningitis syndrome. Inter J Pediat Otorhin. 1982; 4: 77-81

114. Forster G, Sacks S, Christoff N. Aseptic meningitis as a complication of scinticysternography utilizing 111Indium-dtpa. Clin Neurol Neurosurg. 1975; 78: 289-292

Bouomrani S, Trabelsi S, Nouma H, Baïli H, Belgacem N, et al. (2016) Aseptic Noninfective Meningitis: Etiologic Survey. Clin Res Infect Dis 3(5): 1042.

Received : 17 Jun 2016
Accepted : 08 Nov 2016
Published : 10 Nov 2016
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X